JUBLIA is a Topical Solution in the Human Prescription Drug category. It is labeled and distributed by Valeant Pharmaceuticals North America Llc. The primary component is Efinaconazole.
Product ID | 0187-5400_424ea0a1-aaad-43b3-b0be-f78c27e8858c |
NDC | 0187-5400 |
Product Type | Human Prescription Drug |
Proprietary Name | JUBLIA |
Generic Name | Efinaconazole |
Dosage Form | Solution |
Route of Administration | TOPICAL |
Marketing Start Date | 2014-06-06 |
Marketing Category | NDA / NDA |
Application Number | NDA203567 |
Labeler Name | Valeant Pharmaceuticals North America LLC |
Substance Name | EFINACONAZOLE |
Active Ingredient Strength | 100 mg/mL |
Pharm Classes | Azole Antifungal [EPC],Azoles [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2015-12-17 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA203567 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2014-06-06 |
Marketing Category | NDA |
Application Number | NDA203567 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2014-06-06 |
Marketing End Date | 2019-07-24 |
Marketing Category | NDA |
Application Number | NDA203567 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2015-12-17 |
Marketing Category | NDA |
Application Number | NDA203567 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2014-06-06 |
Ingredient | Strength |
---|---|
EFINACONAZOLE | 100 mg/mL |
SPL SET ID: | 922d4d25-c530-11e1-9b21-0800200c9a66 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
JUBLIA 86414520 4775839 Live/Registered |
BAUSCH HEALTH IRELAND LIMITED 2014-10-03 |
JUBLIA 85261969 4359772 Live/Registered |
BAUSCH HEALTH IRELAND LIMITED 2011-03-09 |
JUBLIA 78862951 not registered Dead/Abandoned |
Biovail Laboratories International SRL 2006-04-17 |